Searched for
ODTE
88% retail investors lost money in F&O trading in FY26: SebiIn FY26, an alarming trend emerged in India's equity derivatives market, with nearly 90% of traders facing financial losses. Retail partici...- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Granules unit gets USFDA nod for generic drugGranules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for Amphetamine extended-rel...
- Pfizer launches new medication for migraine treatmentIn a significant breakthrough for migraine sufferers in India, Pfizer has launched Rimegepant ODT, an innovative oral tablet that dissolves...
- Pfizer to acquire Biohaven by early 2023 for $11.6 billionBiohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced that both the companies have entered into an agreement wherein Pfize...
- Easing of lockdown, non-adherence to Covid norms behind surge in infections: Govt"Easing of lockdown combined with pandemic fatigue, lack of community adherence to COVID appropriate behavior and evolution and circulation...
- No deaths due to lack of oxygen specifically reported by states, UTs during second COVID wave: CentreResponding to a question on whether a large number of COVID-19 patients died on roads and hospitals due to acute shortage of oxygen in the ...
- Online portal developed to ascertain O2 demandIt will track the daily allocation of oxygen, their dispatch and deliveries, including movement of oxygen tankers dispatched, delivered, as...
- Hyderabad-based startup helping Centre execute oxygen planThe application currently connects 75 oxygen production plants across the country and helps the ministry monitor the output, demand and tra...
- Stock pick of the week: What makes Cadila Healthcare analysts top betBetter than expected sales and net profit growth, limited impact of US FDA due to its limited exposure, and among other things, have made i...
- Buy Cadila Healthcare, target Rs 444: Equirus SecuritiesBuy Cadila Healthcare Ltd. at a price target of Rs 444.0 .
- Buy Cadila Healthcare Ltd. target Rs 600 : Edelweiss Financial ServicesBuy Cadila Healthcare Ltd. at a price target of Rs 600. Edelweiss says Cadila's US business growth will be best-in-class at 48 per cent wit...
- Dr Reddy's launches generic Lamotrigine tablets in USLamictal is indicated as adjunctive therapy for the certain type of seizures and for the maintenance treatment of bipolar disorder.
- Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
- Glenmark gets USFDA nod for migraine drugGlenmark Pharmaceuticals today said it has received US health regulator's approval to market generic version of Merck's Maxalt MLT tablets.
- Glenmark gets USFDA approval for headache drug"Glenmark will commence distribution of the product immediately," the Mumbai-based firm said.
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Sun Pharma gets USFDA nod for generic schizophrenia tabletsSun Pharmaceutical Industries said it has received approval from the US health regulator for its generic Zyprexa Zydis tablets in the Ameri...
- Ranbaxy drug gets US nodRanbaxy Laboratories got the exclusive rights to market a generic version of Japanese firm Eisai's blockbuster Alzheimer's drug in the US f...
- Sciele Pharma raises 2008 viewSciele Pharma Inc said it is raising its fiscal 2008 earnings and revenue outlook to reflect the acquisition of a product from Verus Pharma...
Load More
